Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

Wael Al Mahmeed¹, Khalid Al-Rasadi², Yajnavalka Banerjee³, Antonio Ceriello⁴, Francesco Cosentino⁵, Massimo Galia⁶, Su-Yen Goh⁷, Peter Kempler⁸, Nader Lessan⁹, Nikolaos Papanas¹⁰, Ali A Rizvi^{11

12}, Raul D Santos^{13

14}, Anca P Stoian¹⁵, Peter P Toth¹⁶, Manfredi Rizzo^{12

15

17}; CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO)

Affiliations

¹ Cleveland Clinic, Heart and Vascular Institute, Abu Dhabi, United Arab Emirates.
² Medical Research Center, Sultan Qaboos University, Muscat, Oman.
³ Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.
⁴ IRCCS MultiMedica, Milan, Italy.
⁵ Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, University of Stockholm, Stockholm, Sweden.
⁶ Department of Biomedicine, Neurosciences and Advanced Diagnostics (Bind), University of Palermo, Palermo, Italy.
⁷ Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.
⁸ Department of Medicine and Oncology, Semmelweis University, Budapest, Hungary.
⁹ Imperial College London Diabetes Centre, The Research Institute, Abu Dhabi, United Arab Emirates.
¹⁰ Second Department of Internal Medicine, Diabetes Center, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
¹¹ Department of Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
¹² Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, IN, United States.
¹³ Heart Institute (InCor) University of Sáo Paulo Medical School Hospital, Sáo Paulo, Brazil.
¹⁴ Hospital Israelita Albert Einstein, Sáo Paulo, Brazil.
¹⁵ Faculty of Medicine, Diabetes, Nutrition and Metabolic Diseases, Carol Davila University, Bucharest, Romania.
¹⁶ Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
¹⁷ Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, Italy.

PMID: 34977193
PMCID: PMC8715947
DOI: 10.3389/fcvm.2021.787761

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

Wael Al Mahmeed et al. Front Cardiovasc Med. 2021.

. 2021 Dec 15:8:787761.

doi: 10.3389/fcvm.2021.787761. eCollection 2021.

Authors

Affiliations

¹ Cleveland Clinic, Heart and Vascular Institute, Abu Dhabi, United Arab Emirates.
² Medical Research Center, Sultan Qaboos University, Muscat, Oman.
³ Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.
⁴ IRCCS MultiMedica, Milan, Italy.
⁵ Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, University of Stockholm, Stockholm, Sweden.
⁶ Department of Biomedicine, Neurosciences and Advanced Diagnostics (Bind), University of Palermo, Palermo, Italy.
⁷ Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.
⁸ Department of Medicine and Oncology, Semmelweis University, Budapest, Hungary.
⁹ Imperial College London Diabetes Centre, The Research Institute, Abu Dhabi, United Arab Emirates.
¹⁰ Second Department of Internal Medicine, Diabetes Center, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
¹¹ Department of Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
¹² Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, IN, United States.
¹³ Heart Institute (InCor) University of Sáo Paulo Medical School Hospital, Sáo Paulo, Brazil.
¹⁴ Hospital Israelita Albert Einstein, Sáo Paulo, Brazil.
¹⁵ Faculty of Medicine, Diabetes, Nutrition and Metabolic Diseases, Carol Davila University, Bucharest, Romania.
¹⁶ Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
¹⁷ Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, Italy.

PMID: 34977193
PMCID: PMC8715947
DOI: 10.3389/fcvm.2021.787761

Abstract

Efforts in the fight against COVID-19 are achieving success in many parts of the world, although progress remains slow in other regions. We believe that a syndemic approach needs to be adopted to address this pandemic given the strong apparent interplay between COVID-19, its related complications, and the socio-structural environment. We have assembled an international, multidisciplinary group of researchers and clinical practitioners to promote a novel syndemic approach to COVID-19: the CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). This geographically diverse group aims to facilitate collaborative-networking and scientific exchanges between researchers and clinicians facing a multitude of challenges on different continents during the pandemic. In the present article we present our "manifesto", with the intent to provide evidence-based guidance to the global medical and scientific community for better management of patients both during and after the current pandemic.

Keywords: COVID-19; cardiovascular diseases; complications; diabetes; pandemic; syndemic.

Copyright © 2021 Al Mahmeed, Al-Rasadi, Banerjee, Ceriello, Cosentino, Galia, Goh, Kempler, Lessan, Papanas, Rizvi, Santos, Stoian, Toth, Rizzo and The CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

**Figure 1**
A novel multi-disciplinary syndemic approach to cardiometabolic diseases during COVID-19.

See this image and copyright information in PMC

References

1. Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, et al. . Issues of cardiovascular risk management in people with diabetes in the COVID-19 era. Diabetes Care. (2020) 43:1427–32. 10.2337/dc20-0941 - DOI - PubMed
1. Khera A, Baum SJ, Gluckman TJ, Gulati M, Martin SS, Michos ED, et al. . Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology. Am J Prev Cardiol. (2020) 1:100009. 10.1016/j.ajpc.2020.100009 - DOI - PMC - PubMed
1. Schnell O, Cos X, Cosentino F, Forst T, Giorgino F, Heersprink HJL, et al. . Report from the CVOT Summit 2020: new cardiovascular and renal outcomes. Cardiovasc Diabetol. (2021) 20:75. 10.1186/s12933-021-01254-1 - DOI - PMC - PubMed
1. Atallah B, El Lababidi R, Jesse W, Noor L, AlMahmeed W. Adapting to the COVID-19 pandemic at a quaternary care hospital in the Middle East Gulf region. Heart Views. (2020) 21:133–40. - PMC - PubMed
1. Ceriello A, Stoian AP, Rizzo M. COVID-19 and diabetes management: What should be considered? Diabetes Res Clin Pract. (2020) 163:108151. 10.1016/j.diabres.2020.108151 - DOI - PMC - PubMed

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

Affiliations

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

LinkOut - more resources

Full Text Sources